Page 29 - மைய மருந்துகள் தரநிலைகள் கட்டுப்பாடு ஆர்கநைஸேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

With 19,078 new COVID-19 cases, India s tally reaches 1,03,05,788

With 19,078 new COVID-19 cases, India s tally reaches 1,03,05,788 ANI | Updated: Jan 02, 2021 23:26 IST New Delhi [India], January 2 (ANI): India reported 19,078 new COVID-19 cases in the last 24 hours, taking the total number of positive cases in the country to 1,03,05,788, the Ministry of Health and Family Welfare (MoHFW) informed on Saturday. The total number of active cases now stands at 2,50,183. As many as 224 people succumbed to coronavirus in the last 24 hours and the death toll has mounted to 1,49,218. So far 99,06,387 recoveries have been reported in the country. As many as 8,29,964 samples tested for the coronavirus on Friday and the count of samples tested so far has reached 17,39,41,658, the Indian Council of Medical Research (ICMR) informed.

Uttar pradeshNew delhiDistrict hospital medical collegeMinistry of healthIndian council of medical researchBharat biotech international ltdHealth facilityCentral drugs standards control organisation onCadila healthcare ltdExpert committeeSerum institute of indiaFamily welfareIndian councilMedical researchWest bengalMedical college

India experts approve AstraZeneca s COVID-19 vaccine

India experts approve AstraZeneca s COVID-19 vaccine Celine Castronuovo © Getty Images India experts approve AstraZeneca s COVID-19 vaccine Experts at India s drug regulatory agency have recommended the coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, along with a second immunization developed by a state-run institute. According to Reuters, the Indian government announced Saturday that a panel at the Central Drugs Standards Control Organisation recommended the AstraZeneca vaccine on Friday, with the agency s chief expected to issue a final decision at a news conference Sunday. The second vaccine, known as Covaxin, was developed by Bharat Biotech and the government-run Indian Council of Medical Research. Reuters reported that sources believed this vaccine would also be quickly approved and distributed, though little information on the findings of the candidate s clinical trial have been released to the public.

Moncef slaouiZydus cadila zycoPrakash javadekarJohns hopkins universityCentral drugs standards control organizationDrug administrationIndian council of medical researchOxford universityGetty images indiaBharat biotechIndian councilBroadcasting minister prakash javadekarZydus cadilaJohns hopkinsOperation warp speedஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம்

AstraZeneca Pharma India : India likely to approve two-dose regimen for COVID vaccines, 4 weeks apart - sources

AstraZeneca Pharma India : India likely to approve two-dose regimen for COVID vaccines, 4 weeks apart - sources
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Astrazeneca oxfordKrishnan dasShilpa jamkhandikarDavid evansBharat biotechCentral drugs standards control organisationகிருஷ்ணன் தாஸ்டேவிட் எவன்ஸ்பாரத் பயோடெக்மைய மருந்துகள் தரநிலைகள் கட்டுப்பாடு ஆர்கநைஸேஶந்

In public interest : Bharat Biotech s Covaxin recommended for emergency approval (Ld)

In public interest : Bharat Biotech s Covaxin recommended for emergency approval (Ld) By IANS | Published on Sat, Jan 2 2021 20:12 IST | 0 Views Bharat Biotech develops India s first vaccine candidate for Covid-19.. Image Source: IANS News New Delhi, Jan 2 : The Central Government on Saturday said that the expert panel of India s drug regulator has recommended granting permission for restricted emergency use of the indigenously developed Covid-19 vaccine Covaxin in public interest as an abundant precaution. The Subject Expert Committee of Central Drugs Standards Control Organisation had met on January 1 and 2, and made the following recommendations for the consideration and final decision of the Drugs Controller General of India. The final decision will be taken by DCGI VG Somani soon.

United statesNew delhiSerum institute of india covishieldBharat biotech internationalNational institute of virologyIndian council of medical researchCentral governmentSubject expert committeeCentral drugs standards control organisationDrugs controller generalIndian councilMedical researchNational instituteSerum instituteஒன்றுபட்டது மாநிலங்களில்புதியது டெல்ஹி

Covid-19 vaccination: All states to conduct dry run on January 2

Covid-19 vaccination: All states to conduct dry run on January 2 The objective of the dry run for Covid-19 vaccine introduction is to assess operational feasibility in the use of COVID-19 Vaccine Intelligence Network. Share Via Email | A+A A- A medic demonstrates administration of COVAXIN COVID-19 vaccine to a health worker during its trials at the Urban Primary Health Centre in Assam. (Photo | PTI) By Express News Service NEW DELHI: Anticipating the approval of Covid-19 vaccines in India soon, the Centre has decided to carry out a dry run of vaccination drive all over the country on Saturday. The activity is proposed to be conducted in all state capitals in at least 3 session sites but some states will also include districts that are situated in difficult terrain or have poor logistical support.

Vaccine intelligence networkCentral drugs standards control organisation on covidNews serviceSerum institute of indiaExpress newsCentral drugs standards control organisationSerum instituteBharat biotechIntelligence networkAndhra pradeshதடுப்பூசி உளவுத்துறை வலைப்பின்னல்செய்தி சேவைசீரம் நிறுவனம் ஆஃப் இந்தியாஎக்ஸ்பிரஸ் செய்திமைய மருந்துகள் தரநிலைகள் கட்டுப்பாடு ஆர்கநைஸேஶந்சீரம் நிறுவனம்